...CEO Jean-Pierre Sommadossi, who helped found two antiviral companies that were acquired in multibillion-dollar deals: Idenix Pharmaceuticals Inc....
...Led by Idenix, Pharmasset co-founder, Atea is fresh off $215M round led by Bain By Jeff... ...veteran biotech entrepreneur who helped found two antiviral companies that were acquired in multibillion-dollar deals: Idenix Pharmaceuticals Inc....
...Inc. (NASDAQ:GILD) following its $11 billion acquisition in 2011. Mayers was EVP and CMO of Idenix Pharmaceuticals Inc.... ...which Merck & Co. Inc. (NYSE:MRK) acquired for $3.9 billion in 2014. The pharma dropped Idenix's...
...Inc. (NASDAQ:GILD) following its $11 billion acquisition in 2011. Mayers was EVP and CMO of Idenix Pharmaceuticals Inc.... ...which Merck & Co. Inc. (NYSE:MRK) acquired for $3.9 billion in 2014. The pharma dropped Idenix's...
...CEO Jean-Pierre Sommadossi, who helped found two antiviral companies that were acquired in multibillion-dollar deals: Idenix Pharmaceuticals Inc....
...Led by Idenix, Pharmasset co-founder, Atea is fresh off $215M round led by Bain By Jeff... ...veteran biotech entrepreneur who helped found two antiviral companies that were acquired in multibillion-dollar deals: Idenix Pharmaceuticals Inc....
...Inc. (NASDAQ:GILD) following its $11 billion acquisition in 2011. Mayers was EVP and CMO of Idenix Pharmaceuticals Inc.... ...which Merck & Co. Inc. (NYSE:MRK) acquired for $3.9 billion in 2014. The pharma dropped Idenix's...
...Inc. (NASDAQ:GILD) following its $11 billion acquisition in 2011. Mayers was EVP and CMO of Idenix Pharmaceuticals Inc.... ...which Merck & Co. Inc. (NYSE:MRK) acquired for $3.9 billion in 2014. The pharma dropped Idenix's...